Literature DB >> 2398471

Nondestructive near-infrared analysis of intact tablets for determination of degradation products.

J K Drennen1, R A Lodder.   

Abstract

Near-infrared spectrometry was used in this study to examine intact aspirin tablets in order to demonstrate the usefulness of the technique as a nondestructive method of quality control. Unique sampling optics were used to simultaneously illuminate the entire surface of the tablets, including the top, bottom, and side. Changes in individual tablet spectra were correlated to (a) the time that the tablets spent in a hydrator, (b) the mass of water absorbed by the tablets, and (c) the mass of salicylic acid formed by base-catalyzed hydrolysis of acetylsalicylic acid. A prediction equation for each of these three parameters was constructed using near-infrared spectral reflectance values obtained from intact tablets. Prediction errors were low for (a) the time that tablets spent in the hydrator (+/- 19 h over a period of 168 h), (b) the mass of water absorbed (+/- 0.04% of tablet mass), and (c) the mass of salicylic acid formed (+/- 0.04% of tablet mass).

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2398471     DOI: 10.1002/jps.2600790717

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  15 in total

1.  Chemometric evaluation of pharmaceutical properties of antipyrine granules by near-infrared spectroscopy.

Authors:  Makoto Otsuka; Yoshifumi Mouri; Yoshihisa Matsuda
Journal:  AAPS PharmSciTech       Date:  2003       Impact factor: 3.246

2.  A novel method for analyzing thick tablets by near infrared spectroscopy.

Authors:  J L Ramirez; M K Bellamy; R J Romañac
Journal:  AAPS PharmSciTech       Date:  2001-07-12       Impact factor: 3.246

3.  Comparative determination of polymorphs of indomethacin in powders and tablets by chemometrical near-infrared spectroscopy and x-ray powder diffractometry.

Authors:  Makoto Otsuka; Fumie Kato; Yoshihisa Matsuda; Yukihiro Ozaki
Journal:  AAPS PharmSciTech       Date:  2003       Impact factor: 3.246

4.  Process analytical technology case study part I: feasibility studies for quantitative near-infrared method development.

Authors:  Robert P Cogdill; Carl A Anderson; Miriam Delgado-Lopez; David Molseed; Robert Chisholm; Raymond Bolton; Thorsten Herkert; Ali M Afnán; James K Drennen
Journal:  AAPS PharmSciTech       Date:  2005-10-06       Impact factor: 3.246

5.  Process analytical technology case study: part II. Development and validation of quantitative near-infrared calibrations in support of a process analytical technology application for real-time release.

Authors:  Robert P Cogdill; Carl A Anderson; Miriam Delgado; Robert Chisholm; Raymond Bolton; Thorsten Herkert; Ali M Afnan; James K Drennen
Journal:  AAPS PharmSciTech       Date:  2005-10-06       Impact factor: 3.246

6.  Assessment of NIR spectroscopy for nondestructive analysis of physical and chemical attributes of sulfamethazine bolus dosage forms.

Authors:  Aditya S Tatavarti; Raafat Fahmy; Huiquan Wu; Ajaz S Hussain; William Marnane; Dennis Bensley; Gary Hollenbeck; Stephen W Hoag
Journal:  AAPS PharmSciTech       Date:  2005-09-20       Impact factor: 3.246

7.  Molecular factor computing for predictive spectroscopy.

Authors:  Bin Dai; Aaron Urbas; Craig C Douglas; Robert A Lodder
Journal:  Pharm Res       Date:  2007-03-23       Impact factor: 4.200

8.  Spectrophotometric prediction of the dissolution rate of carbamazepine tablets.

Authors:  P N Zannikos; W I Li; J K Drennen; R A Lodder
Journal:  Pharm Res       Date:  1991-08       Impact factor: 4.200

9.  Acoustic-resonance spectrometry as a process analytical technology for rapid and accurate tablet identification.

Authors:  Joseph Medendorp; Robert A Lodder
Journal:  AAPS PharmSciTech       Date:  2006-03-17       Impact factor: 3.246

10.  Feasibility of non-invasive measurement of tissue pH using near-infrared reflectance spectroscopy.

Authors:  B R Soller; R H Micheels; J Coen; B Parikh; L Chu; C Hsi
Journal:  J Clin Monit       Date:  1996-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.